ARCHIVES

NCI To Require Reports On Adverse Drug Reactions From Trials

This article is from The Cancer Letter archive.

Vol. 20 No. 23 | June 10, 1994

Download PDF Visit The Full Archive

Related Articles

Also Bristol-Myers Squibb Under Federal Investigation Over Plavix Deal.

July 28, 2006

FDA Reaction to DCT Proposals ‘Positive,’ But Chabner, Wittes ‘Disappointed’ In That Response

June 17, 1988

Publisher, Law Firm Settle Suit Over Newsletter Photocopy

November 15, 1991

Blacks, Whites Have Same Contralateral Breast Cancer Risk While On Tamoxifen

December 31, 2004

NCI Develops Plan For Specialized Centers, But Funding $67.5M Program Depends On New $$

July 5, 1991

R.S.K. Young Quits As FDA Oncology Group Leader

July 11, 1980